Cel Sci CVM
NYSE CVM
$1.42 -0.04 (-2.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Cel Sci (CVM) Net Equity Issued and Repurchased (2011 - 2026)

Cel Sci (CVM) posted Net Equity Issued and Repurchased of $200000.0 for Q1 2026, down 98.73% sequentially from $15.7 million in Q3 2025, and down 90.48% YoY from $2.1 million in Q1 2025.

Cel Sci (CVM) Net Equity Issued and Repurchased (2011 - 2026) Analysis & Trends

Cel Sci has reported Net Equity Issued and Repurchased for 14 years, with the latest figure at $200000.0 in Q1 2026.

  • Quarterly Net Equity Issued and Repurchased fell 90.48% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $18.0 million (changed 0.48% YoY) and the FY2025 annual result came in at $28.3 million, up 20.0% from the prior year.
  • Net Equity Issued and Repurchased slipped to $200000.0 in Q1 2026 per CVM's latest filing, from $15.7 million in the prior quarter.
  • Over five years, Net Equity Issued and Repurchased peaked at $15.7 million in Q3 2025 and troughed at -$13.6 million in Q1 2022.
  • A 5-year average of $4.2 million and a median of $5.0 million in 2023 frame the typical range for Net Equity Issued and Repurchased.
  • The sharpest annual moves came in 2024 and 2026: Net Equity Issued and Repurchased soared 116.9% in 2024, then plunged 90.48% in 2026.
  • Over 5 years, Net Equity Issued and Repurchased stood at -$13.6 million in 2022, then jumped by 136.62% to $5.0 million in 2023, then gained by 0.41% to $5.0 million in 2024, then soared by 214.6% to $15.7 million in 2025, then sank by 98.73% to $200000.0 in 2026.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $200000.0, $15.7 million, and $2.1 million for Q1 2026, Q3 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Cel Sci 2.12 Mn -4.42 Mn - 2.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 200,000.00
Mar 31, 2026 200,000.00
Sep 30, 2025 15.73 Mn
Sep 30, 2025 15.73 Mn
Mar 31, 2025 2.10 Mn
Mar 31, 2025 2.10 Mn
Dec 31, 2024 5.00 Mn
Dec 31, 2024 5.00 Mn
Sep 30, 2024 10.85 Mn
Sep 30, 2024 10.85 Mn
Mar 31, 2024 7.75 Mn
Mar 31, 2024 7.75 Mn
Dec 31, 2023 4.98 Mn
Dec 31, 2023 4.98 Mn
Sep 30, 2023 5.00 Mn
Sep 30, 2023 5.00 Mn
Mar 31, 2022 -13.60 Mn
Mar 31, 2022 -13.60 Mn
Dec 31, 2021 13.60 Mn
Dec 31, 2021 13.60 Mn